Nocturnal cerebral hypoxia in obstructive sleep apnoea: a randomised controlled trial
<p>Cerebral hypoxia may promote cerebral damage in patients with obstructive sleep apnoea (OSA). We investigated whether OSA patients experience nocturnal cerebral hypoxia that is prevented by continuous positive airway pressure (CPAP).</p> <p>OSA patients using CPAP underwent slee...
Κύριοι συγγραφείς: | Schwarz, E, Furian, M, Schlatzer, C, Stradling, J, Kohler, M, Bloch, K |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
European Respiratory Society
2018
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
ECG risk markers for atrial fibrillation and sudden cardiac death in minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised trial.
ανά: Schlatzer, C, κ.ά.
Έκδοση: (2016) -
Effect of CPAP therapy on endothelial function in obstructive sleep apnoea: A systematic review and meta-analysis.
ανά: Schwarz, E, κ.ά.
Έκδοση: (2015) -
Effect of CPAP therapy on endothelial function in obstructive sleep apnoea: A systematic review and meta-analysis
ανά: Schwarz, E, κ.ά.
Έκδοση: (2015) -
Pharmacological approaches to the treatment of obstructive sleep apnoea.
ανά: Kohler, M, κ.ά.
Έκδοση: (2009) -
The role of the nose in the pathogenesis of obstructive sleep apnoea and snoring.
ανά: Kohler, M, κ.ά.
Έκδοση: (2007)